
MNPR vs EVO
$MNPR vs $EVO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
MNPR vs EVO: the quick read
- ·MNPR is the larger company by market cap ($564M vs $559M).
- ·MNPR has been more active on our scanner (31 vs 16 alerts in 30 days).
- ·MNPR has the smaller float (6.0M vs 342.4M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·They trade in different worlds by share price: EVO is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·Both stay busy on our scanner, 31 and 16 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 1% of each other on market cap, which makes the rest of this table the interesting part.
- ·EVO pays a dividend and MNPR does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing MNPR and EVO on TheDesperateTrader.
- Is MNPR or EVO the better stock?
- "Better" depends on your goal, and these two are not alike. MNPR is the larger company by market cap ($564M vs $559M). MNPR has been more active on our scanner (31 vs 16 alerts in 30 days). MNPR has the smaller float (6.0M vs 342.4M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between MNPR and EVO?
- The differences that matter: they are not in the same business - MNPR is pharmaceutical preparations and EVO is pharmaceutical preparations; they are similar in size ($564M vs $559M); they trade at very different share prices ($83.98 vs $1.56); MNPR sits at 45% of its 52-week range against 2% for EVO; only EVO pays a dividend; our scanner flagged MNPR 31 times in the last 30 days against 16 for EVO. Everything above is measured from the latest completed session and SEC filings.
- Which of MNPR and EVO is more active right now?
- Right now MNPR is at about 1.2x its normal volume and EVO is at about 0.7x, so MNPR is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading MNPR or EVO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.